{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:10:28Z","timestamp":1790511028341,"version":"4.1.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12,13]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Two years of antiviral prophylaxis and VZV vaccination reduce the incidence of VZV disease and nearly eliminate post\u2013herpetic neuralgia.<\/jats:p>","DOI":"10.1182\/bloodadvances.2016000836","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T21:34:09Z","timestamp":1480541649000},"page":"152-159","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":20,"title":["Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir\/valacyclovir followed by vaccination"],"prefix":"10.1182","volume":"1","author":[{"given":"Kareem","family":"Jamani","sequence":"first","affiliation":[{"name":"Alberta Blood and Marrow Transplant Program, University of Calgary and Alberta Health Services, Calgary, AB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada;"},{"name":"Population, Public and Aboriginal Health, Alberta Health Services, Calgary, AB, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lavoie","sequence":"additional","affiliation":[{"name":"Alberta Health, Government of Alberta, Edmonton, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler S.","family":"Williamson","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Brown","sequence":"additional","affiliation":[{"name":"Alberta Blood and Marrow Transplant Program, University of Calgary and Alberta Health Services, Calgary, AB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsan","family":"Chaudhry","sequence":"additional","affiliation":[{"name":"Alberta Blood and Marrow Transplant Program, University of Calgary and Alberta Health Services, Calgary, AB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor H.","family":"Jimenez-Zepeda","sequence":"additional","affiliation":[{"name":"Alberta Blood and Marrow Transplant Program, University of Calgary and Alberta Health Services, Calgary, AB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Duggan","sequence":"additional","affiliation":[{"name":"Alberta Blood and Marrow Transplant Program, University of Calgary and Alberta Health Services, Calgary, AB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Tay","sequence":"additional","affiliation":[{"name":"Alberta Blood and Marrow Transplant Program, University of Calgary and Alberta Health Services, Calgary, AB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Stewart","sequence":"additional","affiliation":[{"name":"Alberta Blood and Marrow Transplant Program, University of Calgary and Alberta Health Services, Calgary, AB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Daly","sequence":"additional","affiliation":[{"name":"Alberta Blood and Marrow Transplant Program, University of Calgary and Alberta Health Services, Calgary, AB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Storek","sequence":"additional","affiliation":[{"name":"Alberta Blood and Marrow Transplant Program, University of Calgary and Alberta Health Services, Calgary, AB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2016,11,30]]},"reference":[{"key":"2019111609120146000_B1","article-title":"Varicella Zoster Virus Infections","author":"Ho","year":"2016","edition":"5th ed."},{"key":"2019111609120146000_B2","author":"Marr","year":"2012"},{"key":"2019111609120146000_B3","author":"Rogers","year":"2011"},{"key":"2019111609120146000_B4","author":"Blennow","year":"2014"},{"key":"2019111609120146000_B5","author":"Doki","year":"2013"},{"key":"2019111609120146000_B6","author":"Koc","year":"2000"},{"issue":"6","key":"2019111609120146000_B7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/infdis\/152.6.1172","article-title":"Infection with varicella-zoster virus after marrow transplantation","volume":"152","author":"Locksley","year":"1985","journal-title":"J Infect Dis"},{"issue":"10","key":"2019111609120146000_B8","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1086\/320157","article-title":"A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation","volume":"32","author":"Offidani","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2019111609120146000_B9","first-page":"185","article-title":"Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro","volume":"1","author":"Ljungman","year":"1986","journal-title":"Bone Marrow Transplant"},{"key":"2019111609120146000_B10","first-page":"99","article-title":"Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation","volume":"85","author":"Perren","year":"1988","journal-title":"Am J Med"},{"issue":"3","key":"2019111609120146000_B11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1989.88","article-title":"The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation","volume":"59","author":"Selby","year":"1989","journal-title":"Br J Cancer"},{"issue":"5","key":"2019111609120146000_B12","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh","year":"2006","journal-title":"Blood"},{"issue":"11","key":"2019111609120146000_B13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bmt.1704959","article-title":"The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation","volume":"35","author":"Thomson","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2019111609120146000_B14","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"},{"key":"2019111609120146000_B15","author":"Pollack","year":"2011"},{"key":"2019111609120146000_B16","author":"Distler","year":"2008"},{"key":"2019111609120146000_B17","author":"Chou","year":"2011"},{"issue":"11","key":"2019111609120146000_B18","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/bmt.2010.31","article-title":"Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs","volume":"45","author":"Kussmaul","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2019111609120146000_B19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1700909","article-title":"Varicella vaccination in children after bone marrow transplantation","volume":"20","author":"Sauerbrei","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2019111609120146000_B20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"2019111609120146000_B21","unstructured":"Public Health & Compliance Division AH. Immunization for Adult Hematopoietic Stem Cell Transplant Recipients. Alberta Immunization Policy-Special Situations for Immunization 2007; http:\/\/www.health.alberta.ca\/documents\/AIP-Special-Situations-Adult-Hematopoietic-Stem-Cell-Transplant-HSCT.pdf. Accessed September 16, 2016."},{"key":"2019111609120146000_B22","author":"Russell","year":"2008"},{"key":"2019111609120146000_B23","author":"Russell","year":"2010"},{"issue":"6","key":"2019111609120146000_B24","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111609120146000_B25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"2019111609120146000_B26","author":"Filipovich","year":"2005"},{"issue":"11","key":"2019111609120146000_B27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40266-012-0014-3","article-title":"Diagnosing and managing postherpetic neuralgia","volume":"29","author":"Nalamachu","year":"2012","journal-title":"Drugs Aging"},{"key":"2019111609120146000_B28","author":"Boeckh","year":"2006"},{"key":"2019111609120146000_B29","author":"Arai","year":"2015"},{"issue":"2","key":"2019111609120146000_B30","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1182\/blood-2004-03-1000","article-title":"Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors","volume":"105","author":"Remberger","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2019111609120146000_B31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1702190","article-title":"Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir","volume":"25","author":"Steer","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"2019111609120146000_B32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-8-37","article-title":"The impact of herpes zoster and post-herpetic neuralgia on quality-of-life","volume":"8","author":"Johnson","year":"2010","journal-title":"BMC Med"},{"key":"2019111609120146000_B33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1477-7525-12-92","article-title":"Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) study","volume":"12","author":"Serpell","year":"2014","journal-title":"Health Qual Life Outcomes"},{"issue":"22","key":"2019111609120146000_B34","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"2019111609120146000_B35","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J Infect Dis"},{"issue":"7","key":"2019111609120146000_B36","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/529043","article-title":"Primary vaccine failure after 1 dose of varicella vaccine in healthy children","volume":"197","author":"Michalik","year":"2008","journal-title":"J Infect Dis"},{"issue":"21","key":"2019111609120146000_B37","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2015.03.055","article-title":"Varicella in Europe---a review of the epidemiology and experience with vaccination","volume":"33","author":"Helmuth","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"2019111609120146000_B38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/171.1.13","article-title":"Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine","volume":"171","author":"Nader","year":"1995","journal-title":"J Infect Dis"},{"key":"2019111609120146000_B39","author":"Tomblyn","year":"2009"},{"issue":"10","key":"2019111609120146000_B40","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3109\/14653249.2012.715243","article-title":"Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation","volume":"14","author":"Bosch","year":"2012","journal-title":"Cytotherapy"},{"issue":"1","key":"2019111609120146000_B41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/IAI.25.1.170-174.1979","article-title":"Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections","volume":"25","author":"Gershon","year":"1979","journal-title":"Infect Immun"},{"issue":"2","key":"2019111609120146000_B42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archinte.1982.00340150091017","article-title":"Immune responses to varicella-zoster in the aged","volume":"142","author":"Burke","year":"1982","journal-title":"Arch Intern Med"},{"issue":"4","key":"2019111609120146000_B43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s15010-006-5616-9","article-title":"Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination","volume":"34","author":"Ludwig","year":"2006","journal-title":"Infection"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/2\/152\/877638\/advances000836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/2\/152\/877638\/advances000836.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T16:49:04Z","timestamp":1601225344000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/2\/152\/15518\/Zoster-prophylaxis-after-allogeneic-hematopoietic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,30]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,12,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2016000836","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,30]]}}}